A phase II, multicenter, open-label, randomized trial investigating SM-88 for the treatment of pancreatic cancer

Trial Profile

A phase II, multicenter, open-label, randomized trial investigating SM-88 for the treatment of pancreatic cancer

Planning
Phase of Trial: Phase II

Latest Information Update: 13 Apr 2016

At a glance

  • Drugs SM 88 (Primary)
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Apr 2016 New trial record
    • 11 Apr 2016 According to a Tyme Technologies media release, this trial is expected to start in 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top